Jefferies Downgrades Ipsen to Underperform, Boosts PT

MT Newswires · 2d ago
08:35 AM EDT, 08/03/2026 (MT Newswires) -- Jefferies on Monday downgraded biopharmaceutical company Ipsen (IPN.PA) to underperform from hold and increased its price target to 135.00 euros from 117.00 euros. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)